| __timestamp | Bausch Health Companies Inc. | Geron Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 20707000 |
| Thursday, January 1, 2015 | 582800000 | 17831000 |
| Friday, January 1, 2016 | 455000000 | 18047000 |
| Sunday, January 1, 2017 | 366000000 | 11033000 |
| Monday, January 1, 2018 | 414000000 | 13432000 |
| Tuesday, January 1, 2019 | 471000000 | 52072000 |
| Wednesday, January 1, 2020 | 452000000 | 51488000 |
| Friday, January 1, 2021 | 465000000 | 85727000 |
| Saturday, January 1, 2022 | 529000000 | 95518000 |
| Sunday, January 1, 2023 | 604000000 | 125046000 |
Data in motion
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) expenses are a critical indicator of a company's commitment to innovation. Over the past decade, Bausch Health Companies Inc. and Geron Corporation have demonstrated contrasting approaches to R&D investment.
Bausch Health has consistently allocated substantial resources to R&D, with a notable increase of approximately 145% from 2014 to 2023. This upward trend underscores their strategic focus on expanding their product pipeline and enhancing existing offerings. In contrast, Geron Corporation, while smaller in scale, has shown a remarkable 500% increase in R&D spending over the same period, reflecting their aggressive pursuit of breakthrough therapies in oncology.
These trends highlight the dynamic nature of the pharmaceutical industry, where strategic R&D investments can drive innovation and potentially lead to life-changing medical advancements.
Biogen Inc. vs Geron Corporation: Strategic Focus on R&D Spending
Neurocrine Biosciences, Inc. vs Bausch Health Companies Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Geron Corporation
Pharming Group N.V. or Bausch Health Companies Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Grifols, S.A. and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for ADMA Biologics, Inc. and Bausch Health Companies Inc.
Research and Development Expenses Breakdown: Amneal Pharmaceuticals, Inc. vs Geron Corporation
Xenon Pharmaceuticals Inc. or Geron Corporation: Who Invests More in Innovation?
Cost Insights: Breaking Down Bausch Health Companies Inc. and Geron Corporation's Expenses
R&D Insights: How Supernus Pharmaceuticals, Inc. and Geron Corporation Allocate Funds
Research and Development Investment: Soleno Therapeutics, Inc. vs Geron Corporation
Comparing Innovation Spending: Geron Corporation and Viridian Therapeutics, Inc.